Educational Intervention to Promote Control Behaviors and Prevention of Dengue

December 22, 2023 updated by: Universidad de Antioquia

Nursing Intervention in Adults to Promote Dengue Prevention and Control Behaviors

This study will assess the effect of an educational nursing intervention in adults to promote dengue control and prevention behaviors, in comparison with the usual strategy of a health service provider institution. The intervention uses the Nola Pender Health Promotion Model as a theoretical framework. Findings will be assessed using the nursing outcomes "risk control" and "participation in health care decisions" from the Nursing Outcomes Classification (NOC).

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Annually, there are 390 million cases of dengue, mostly due to the inadequate application of sanitary behaviors in the management and control of the vector, having as background the lack of knowledge of the population in the appropriation and incorporation of sanitary measures in the different environments. In addition to the cognitive and behavioral component, dengue has cultural, political, social and economic causes.

The evidence indicates that, from health education, educational interventions have been developed to reduce the disease, but most of them have not been carried out in rural areas following a theoretical framework that guides the intervention that leads to an impact on health promoting behaviors.

The use of the NOC results makes it possible to visualize the impact of nursing care and constitute scientific support for the advancement of the nursing discipline.

Study Type

Interventional

Enrollment (Actual)

116

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Colombia
    • Antioquia
      • Medellín, Antioquia, Colombia
        • Yolima Judith Llorente Perez
        • Contact:
        • Principal Investigator:
          • Yolima J Llorente Perez, MSc
        • Sub-Investigator:
          • Alba L Rodriguez Acelas, PhD
        • Sub-Investigator:
          • Rita Mattiello, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 99 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults ≥ 18 years old.
  • Inhabitant of the rural area.
  • Participant in health promotion and disease prevention programs.
  • Initial score less than or equal to 3.5 on the NOC outcomes: risk control and participation in health care decisions.

Exclusion Criteria:

  • People with a score less than or equal to 24 on the cognitive mini mental test.
  • Incomplete registration of information in databases of a health service provider institution.
  • People with dengue (dengue with warning signs, and severe dengue).
  • People who do not have mobile phone availability.
  • Illiterate people.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
The intervention is defined as educational support (improving the knowledge of the disease, identification of risks and consequences), behavioral support (promoting skills related to personal, home, and environmental self-care) and attitudinal support (reflecting on benefits and risks).
Behavioral: Educational nursing intervention
Four weekly individualized intervention sessions, with a duration of 40 minutes.
No Intervention: Control
Control group will receive the usual strategy of a health service provider institution.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Risk control
Time Frame: 2 months
NOC outcome. Personal actions to understand, prevent, eliminate, or reduce modifiable health threats. It includes indicators such as identifies risk factors, acknowledges ability to change behavior, develops effective risk control strategies, commits to risk control strategies and modifies lifestyle to reduce risk. This outcome will be evaluated by a Likert scale, being 1 the worst score and 5 best score.
2 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participation in health care decisions
Time Frame: 2 months
NOC outcome. Personal involvement in selecting and evaluating health care options to achieve desired outcome. It includes indicators such as identifies health outcome priorities, specifies health outcome preference and identifies barriers to desired outcome achievement. This outcome will be evaluated by a Likert scale, being 1 the worst score and 5 best score.
2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universidad de Antioquia

Investigators

  • Study Director: Wilson Canon Montanez, PhD, Universidad de Antioquia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 9, 2023

Primary Completion (Actual)

October 14, 2023

Study Completion (Actual)

November 21, 2023

Study Registration Dates

First Submitted

April 1, 2022

First Submitted That Met QC Criteria

April 1, 2022

First Posted (Actual)

April 11, 2022

Study Record Updates

Last Update Posted (Actual)

December 29, 2023

Last Update Submitted That Met QC Criteria

December 22, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2021-29

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dengue

Clinical Trials on Educational nursing intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe